Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Hamilton Lane is a specialized private markets investment manager with $1.1 trillion in assets under management and supervision, providing fund-of-funds, customized separate accounts, and advisory services primarily to institutional investors. The firm operates across private equity, private credit, real estate, infrastructure, and venture capital, generating revenue through management fees (typically 50-75 bps on committed capital) and performance-based incentive fees (carried interest). Its competitive advantage lies in proprietary data analytics covering 70,000+ private market funds and deep institutional relationships built over 30+ years.
Hamilton Lane earns predictable management fees on committed capital regardless of deployment status, creating high-margin recurring revenue with 70%+ gross margins. The firm's pricing power stems from institutional-grade infrastructure, proprietary fund performance databases, and co-investment access that smaller competitors cannot replicate. Performance fees provide asymmetric upside when portfolio companies exit at valuations exceeding hurdle rates. The business benefits from significant operating leverage as incremental AUM requires minimal additional headcount due to scalable technology platforms.
Quarterly net fundraising and AUM growth - institutional commitments to new fund vintages drive forward fee revenue
Realization activity and carried interest recognition - exits from 2015-2018 vintage funds currently driving incentive fee acceleration
Fee-earning AUM conversion rates - percentage of committed capital actually deployed and generating management fees
Private market valuation environment - mark-to-market adjustments on existing portfolio holdings affect reported performance and future fundraising
Institutional allocation trends to private markets - pension funds and endowments increasing target allocations from 10% to 15-20%
Fee compression from mega-managers (Blackstone, KKR, Apollo) leveraging scale to offer lower management fees on $100B+ flagship funds, potentially pressuring Hamilton Lane's 50-75 bps pricing
Regulatory scrutiny of private markets - SEC proposals for quarterly reporting, fee transparency, and preferential liquidity terms could increase compliance costs and reduce institutional appeal
Denominator effect - if public equity declines cause private assets to exceed target allocations, institutions may pause commitments until rebalancing occurs, as seen in 2022-2023
Direct competition from Blackstone Strategic Partners, Goldman Sachs Alternatives, and StepStone for institutional separate account mandates exceeding $1B
Disintermediation risk as largest pension funds (CalPERS, CPPIB) build internal teams to invest directly rather than paying external management fees
Limited balance sheet risk given strong liquidity (113x current ratio) and modest leverage, though $350M debt used for general partner commitments creates modest interest rate exposure
Clawback provisions on previously distributed carried interest if later fund investments underperform, though unlikely given diversification across 500+ underlying funds
moderate - Management fees provide stable recurring revenue insulated from quarterly GDP fluctuations, but fundraising activity and carried interest realizations are procyclical. Strong economic growth drives M&A exit activity (increasing performance fees) and corporate earnings growth (boosting portfolio valuations). However, the 7-10 year investment horizon smooths short-term volatility. Institutional investors maintain strategic allocations through cycles, though deployment pacing may slow during recessions.
Rising rates create mixed effects: (1) Negative for valuation multiples as alternative asset managers trade at premium P/E ratios that compress when risk-free rates rise, explaining the 23% stock decline despite strong fundamentals. (2) Negative for portfolio company valuations as higher discount rates reduce private equity exit multiples by 1-2 turns. (3) Positive for private credit strategies where floating-rate loans reprice higher, increasing returns and fundraising appeal. (4) Neutral for management fees which are contractually locked for 10+ year fund lives. Net impact currently negative given rate normalization from zero.
Moderate exposure through two channels: (1) Private credit strategies ($25B+ AUM) directly invest in leveraged loans and direct lending, benefiting from wider spreads but facing higher default risk in credit stress. (2) Portfolio company leverage - typical buyout carries 5-6x EBITDA debt, making exits vulnerable to credit market disruptions that freeze leveraged finance markets. However, the firm has minimal balance sheet leverage (0.50 D/E) and no funding risk, unlike banks or BDCs.
growth - Investors attracted to 25-30% revenue growth, expanding margins, and secular tailwinds from institutional allocation increases to private markets. The stock trades at 8.8x sales (premium to traditional asset managers at 3-5x) reflecting growth expectations and high ROE of 29%. Recent 25% drawdown creates entry point for growth investors believing private market adoption continues. Not a dividend story despite 1.5% yield, as capital prioritized for GP commitments and technology investment.
moderate-high - Beta approximately 1.3-1.5 to broader market given sensitivity to risk appetite and valuation multiple compression. Stock experiences 20-30% drawdowns during risk-off periods when alternative asset managers de-rate alongside private equity valuations. Quarterly volatility driven by lumpy carried interest recognition and mark-to-market adjustments. Less volatile than pure-play private equity firms (ARES, BX) due to diversified fund-of-funds model, but more volatile than traditional mutual fund managers.
